WELCOME TO MEANWAP

After concerns on safety triggered a pause, AstraZeneca has resumed clinical trial of it’s vaccine . AstraZeneca Plc and the University of Oxford have resumed the British clinical trials of its Covid-19 vaccine, after the initial suspension over concerns with a participant who fell ill. University of Oxford, in a statement, said that the UK regulator, Medicines Health Regulatory Authority (MHRA), had recommended a restart of the trials, after an independent review of the safety data triggered a pause on September 6. It revealed some 18,000 people have received ‘study vaccines’ as part of the trials, but declined to disclose any details about the participant’s illness, for confidentiality reasons. AstraZeneca Plc said,  “The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume. The statements from both AstraZeneca Plc and the University of Oxford did not make any disclosure about the status of tests outside the UK lthough...

  Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill. “Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so,” the company said in a statement. AstraZeneca announced on Wednesday it had “voluntarily paused” its trial of the vaccine developed alongside Oxford University after the volunteer developed an unexplained illness. An independent committee was drafted in to review safety, in what the company and the World Health Organization described as a routine step. The committee “has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume”, AstraZeneca said. Oxford University confirmed the resumption and said: “In large trials such as this, it i...

The United States was supported only by Israel Friday in a vote against a UN resolution for a “comprehensive and coordinated response” to the Covid-19 pandemic, a text that included recognition of the WHO’s leadership role. The measure, which has been negotiated since May, was adopted by an overwhelming majority of 169 countries out of 193, with Ukraine and Hungary abstaining. The text, called an omnibus resolution because it covers multiple aspects of the pandemic, “acknowledges the key leadership role of WHO and the fundamental role of the United Nations system in catalyzing and coordinating the comprehensive global response to the Covid-19 pandemic.” The United States withdrew from the WHO this spring, accusing the body of mismanaging the coronavirus pandemic and delaying launch of a global alert. The text “calls for intensified international cooperation and solidarity to contain, mitigate and overcome the pandemic and its consequences.” And it supports UN Secretary-General Antonio ...